Acadia Healthcare Company, Inc. (FRA:7RA)
Germany · Delayed Price · Currency is EUR 12.30
-0.20 (-1.60%)
Last updated: Jan 26, 2026, 8:14 AM CET
Acadia Healthcare Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 3,266 | 3,154 | 2,929 | 2,610 | 2,314 | 2,090 | |
Revenue Growth (YoY) | 4.58% | 7.69% | 12.20% | 12.79% | 10.74% | 4.06% |
Cost of Revenue | 1,901 | 1,804 | 1,678 | 1,494 | 1,335 | 1,242 |
Gross Profit | 1,364 | 1,350 | 1,250 | 1,117 | 979.89 | 848.17 |
Selling, General & Admin | 242.34 | 237.57 | 222.57 | 203.48 | 175.26 | 157.85 |
Other Operating Expenses | 495.09 | 440.79 | 388.91 | 349.28 | 301.34 | 262.27 |
Operating Expenses | 920.47 | 827.95 | 743.82 | 670.52 | 583.31 | 515.38 |
Operating Income | 443.78 | 522.28 | 506.6 | 446.24 | 396.57 | 332.79 |
Interest Expense | -131.01 | -116.37 | -82.13 | -69.76 | -76.99 | -158.11 |
Other Non Operating Income (Expenses) | -33.66 | -35.59 | -21.7 | -3.48 | - | - |
EBT Excluding Unusual Items | 279.12 | 370.32 | 402.77 | 373 | 319.58 | 174.68 |
Merger & Restructuring Charges | -7.37 | -18.68 | -10.79 | -0.2 | -7.44 | -13 |
Gain (Loss) on Sale of Assets | 8.72 | - | 9.75 | - | - | - |
Asset Writedown | - | - | - | - | -23.19 | - |
Legal Settlements | -119.14 | -4.8 | -402.98 | -2.6 | - | - |
Other Unusual Items | -19.85 | -4.96 | -24.11 | 3.94 | -13.19 | 22.12 |
Pretax Income | 141.46 | 341.88 | -25.36 | 374.14 | 275.76 | 183.8 |
Income Tax Expense | 22.62 | 77.4 | -9.7 | 94.11 | 67.56 | 40.61 |
Earnings From Continuing Operations | 118.85 | 264.48 | -15.66 | 280.03 | 208.2 | 143.19 |
Earnings From Discontinued Operations | - | - | - | - | -12.64 | -812.39 |
Net Income to Company | 118.85 | 264.48 | -15.66 | 280.03 | 195.56 | -669.2 |
Minority Interest in Earnings | -11.48 | -8.87 | -6.01 | -6.89 | -4.93 | -2.93 |
Net Income | 107.36 | 255.61 | -21.67 | 273.14 | 190.64 | -672.13 |
Net Income to Common | 107.36 | 255.61 | -21.67 | 273.14 | 190.64 | -672.13 |
Net Income Growth | -61.76% | - | - | 43.28% | - | - |
Shares Outstanding (Basic) | 91 | 92 | 91 | 90 | 89 | 88 |
Shares Outstanding (Diluted) | 91 | 92 | 91 | 92 | 91 | 89 |
Shares Change (YoY) | -0.53% | 1.22% | -0.66% | 0.84% | 2.48% | 0.89% |
EPS (Basic) | 1.18 | 2.79 | -0.24 | 3.05 | 2.15 | -7.65 |
EPS (Diluted) | 1.18 | 2.78 | -0.24 | 2.98 | 2.10 | -7.59 |
EPS Growth | -61.31% | - | - | 41.85% | - | - |
Free Cash Flow | -347.22 | -560.69 | 38.21 | 84.42 | 129.67 | 433.84 |
Free Cash Flow Per Share | -3.80 | -6.09 | 0.42 | 0.92 | 1.43 | 4.90 |
Gross Margin | 41.78% | 42.81% | 42.70% | 42.78% | 42.34% | 40.58% |
Operating Margin | 13.59% | 16.56% | 17.30% | 17.09% | 17.14% | 15.92% |
Profit Margin | 3.29% | 8.10% | -0.74% | 10.46% | 8.24% | -32.16% |
Free Cash Flow Margin | -10.63% | -17.78% | 1.31% | 3.23% | 5.60% | 20.76% |
EBITDA | 626.82 | 671.87 | 638.95 | 564.01 | 503.29 | 428.04 |
EBITDA Margin | 19.20% | 21.30% | 21.82% | 21.61% | 21.75% | 20.48% |
D&A For EBITDA | 183.04 | 149.6 | 132.35 | 117.77 | 106.72 | 95.26 |
EBIT | 443.78 | 522.28 | 506.6 | 446.24 | 396.57 | 332.79 |
EBIT Margin | 13.59% | 16.56% | 17.30% | 17.09% | 17.14% | 15.92% |
Effective Tax Rate | 15.99% | 22.64% | - | 25.15% | 24.50% | 22.09% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.